$NeoGenomics(NEO)$ view order

$NeoGenomics(NEO)$ view order details.@Trade Feed Decoder

NEO

07-17 03:57

USNeoGenomics

Side	Price \| Filled	Realized P&L
Buy Open	6.90 100	+71.02% Holding

NeoGenomics

Trade Feed: Who is your favorite trader?

Come to the Trade Feed Topic to find more trading opportunities! Also, please feel free to recommend and introduce fellow Tigers to the "hidden gem traders" that you've discovered!

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Trade Feed Decoder
07-17
Trade Feed Decoder
This NEO trade shows a 1.89% gain on a long position, suggesting effective short-term execution. The oncology diagnostics sector often sees volatility around clinical trial updates or regulatory news, which might have influenced the entry. While the profit appears modest, it reflects disciplined exit timing given the stock's 52-week beta of ~1.3 indicating moderate volatility. Position sizing remains unclear without trade value context – critical for evaluating risk management in this $1.3B market cap company. The trade aligns with momentum strategies given recent institutional accumulation observed in Q1 filings. However, investors should cross-verify with the company's cash burn rate (-$85M TTM) and growing competition in liquid biopsy markets when assessing sustainability of price movements.

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":457491778572680,"tweetId":"457491778572680","gmtCreate":1752696032140,"gmtModify":1765348813688,"author":{"id":4100905020191520,"idStr":"4100905020191520","authorId":4100905020191520,"authorIdStr":"4100905020191520","name":"Hanxl","avatar":"https://community-static.tradeup.com/news/ed5377213095ccfa8c01237efa98846b","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":13,"crmLevelSwitch":1,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.11.27","exceedPercentage":"93.20%","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":105,"starInvestorFlag":true,"fullDisclosureFlag":true,"starInvestorFollowerNum":102,"starInvestorOrderShareNum":355,"userFollowInvestorFlag":false,"orderNotificationFlag":false,"ror":76.76,"showRor":true,"winRationPercentage":81.518482,"tradeVolumeEst":0},"themes":[{"themeId":"4e1ab37448a24dd39b7882426fc6fd27","categoryId":"ab3d937a5fd848c08008411a9be702b5","name":"Trade Feed: Who is your favorite trader?","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":4e1ab37448a24dd39b7882426fc6fd27}&rnconfig={\"headerBarHidden\": true}","description":"Come to the Trade Feed Topic to find more trading opportunities! Also, please feel free to recommend and introduce fellow Tigers to the \"hidden gem traders\" that you've discovered!","image":"https://community-static.tradeup.com/news/e496e574dd744490c7b4f7959f83f5a4"}],"images":[],"coverImages":[],"html":"<html><head></head><body><a href=\"https://ttm.financial/S/NEO\">$NeoGenomics(NEO)$&nbsp;</a>view order details.<a href=\"https://ttm.financial/U/10000000000011061\">@Trade Feed Decoder</a></body></html>","htmlText":"<html><head></head><body><a href=\"https://ttm.financial/S/NEO\">$NeoGenomics(NEO)$&nbsp;</a>view order details.<a href=\"https://ttm.financial/U/10000000000011061\">@Trade Feed Decoder</a></body></html>","text":"$NeoGenomics(NEO)$ view order details.@Trade Feed Decoder","highlighted":1,"essential":1,"paper":1,"likeSize":34,"commentSize":1,"repostSize":14,"favoriteSize":0,"link":"https://ttm.financial/post/457491778572680","repostId":0,"isVote":1,"tweetType":1,"viewCount":1408,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["NEO"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":true,"orderData":{"uuid":"4100905020191520","orderId":"39816867470249984","kind":"TRADE","symbol":"NEO","secType":"STK","symbolHtmlTag":"<a href=\"https://ttm.financial/S/NEO\">$NeoGenomics(NEO)$&nbsp;</a>","symbolHtmlTagHref":"https://ttm.financial/S/NEO","symbolName":"NeoGenomics","market":"US","action":"BUY","currency":"USD","symbolLogo":"","showFilledQuantity":true,"nameCN":"NeoGenomics","orderType":"LMT","filledQuantityFinal":100,"avgFillPrice":6.9,"createTime":1752695841,"filledQuantity":"100","filledQuantityScale":"0","openFlag":true,"side":"DEBIT","contractMajorDescription":"NeoGenomics","contractExtraDescription":"NEO","legs":[],"completedFlag":false,"orderPnl":{"openRealizedPnlPercent":0,"openUnrealizedPnlPercent":0.7102},"quickOrderFlag":false},"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":["订单分享帖","未分享订单分享帖"],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":34,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":457501504180560,"commentId":"457501504180560","gmtCreate":1752702043412,"gmtModify":1752702324890,"authorId":10000000000011060,"author":{"id":10000000000011060,"idStr":"10000000000011061","authorId":10000000000011060,"name":"Trade Feed Decoder","avatar":"https://community-static.tradeup.com/news/4dc8fec78bad5acffbf563bdbc6bc8ed","vip":4,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":457491778572680,"objectIdStr":"457491778572680","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"This NEO trade shows a 1.89% gain on a long position, suggesting effective short-term execution. The oncology diagnostics sector often sees volatility around clinical trial updates or regulatory news, which might have influenced the entry. While the profit appears modest, it reflects disciplined exit timing given the stock's 52-week beta of ~1.3 indicating moderate volatility. Position sizing remains unclear without trade value context – critical for evaluating risk management in this $1.3B market cap company. The trade aligns with momentum strategies given recent institutional accumulation observed in Q1 filings. However, investors should cross-verify with the company's cash burn rate (-$85M TTM) and growing competition in liquid biopsy markets when assessing sustainability of price movements.","text":"This NEO trade shows a 1.89% gain on a long position, suggesting effective short-term execution. The oncology diagnostics sector often sees volatility around clinical trial updates or regulatory news, which might have influenced the entry. While the profit appears modest, it reflects disciplined exit timing given the stock's 52-week beta of ~1.3 indicating moderate volatility. Position sizing remains unclear without trade value context – critical for evaluating risk management in this $1.3B market cap company. The trade aligns with momentum strategies given recent institutional accumulation observed in Q1 filings. However, investors should cross-verify with the company's cash burn rate (-$85M TTM) and growing competition in liquid biopsy markets when assessing sustainability of price movements.","html":"This NEO trade shows a 1.89% gain on a long position, suggesting effective short-term execution. The oncology diagnostics sector often sees volatility around clinical trial updates or regulatory news, which might have influenced the entry. While the profit appears modest, it reflects disciplined exit timing given the stock's 52-week beta of ~1.3 indicating moderate volatility. Position sizing remains unclear without trade value context – critical for evaluating risk management in this $1.3B market cap company. The trade aligns with momentum strategies given recent institutional accumulation observed in Q1 filings. However, investors should cross-verify with the company's cash burn rate (-$85M TTM) and growing competition in liquid biopsy markets when assessing sustainability of price movements.","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"hot","coins":0,"score":0,"disclaimerFlag":true,"disclaimerType":1,"specialCommentTag":"AI_ANALYSE"}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/457491778572680"}